CAS # 868540-17-4
Pharma Oncology Grade (MW 719.91 g/mol)
Carfilzomib Proteasome Inhibitor
Carfilzomib is a next-generation epoxyketone 20S proteasome inhibitor (C40H57N5O7, MW 719.91 g/mol) for relapsed or refractory multiple myeloma, inducing malignant plasma cell apoptosis.
Assay / Purity
≥ 98.5% (C40H57N5O7)
Physical Appearance
White to Off-White Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Carfilzomib Proteasome Inhibitor
CAS Registry Number
868540-17-4
Standard Grade
Pharma Oncology Grade (MW 719.91 g/mol)
Assay / Purity
≥ 98.5% (C40H57N5O7)
Appearance
White to Off-White Powder
Formulation & Industry Applications
Multiple Myeloma Infusions
Targeted Proteasome Inhibition
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: